Published: 9 February 2023
Author(s): Xue Tian, Shuohua Chen, Yijun Zhang, Xiaoli Zhang, Qin Xu, Penglian Wang, Shouling Wu, Yanxia Luo, Anxin Wang
Issue: June 2023
Section: Original article

Serum uric acid (SUA) is an end product of purine nucleotide catabolism arising from endogenous and exogenous sources [1,2]. The SUA levels are rigorously controlled by the balance between SUA production and excretion [3]. Excess production or reduced excretion can lead to elevated SUA, which has been reported to be associated with various adverse health outcomes, such as hypertension, diabetes, dyslipidemia, and renal dysfunction, in the observational studies and an umbrella systemic review [4–8].

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.